Boston Scientific

Alnylam Pharmaceuticals

UnitedHealth Group

Intuitive Surgical

Insulet

Exact Sciences

Danaher

Regeneron Pharmaceuticals

Stryker

Eli Lilly

Fidelity Disruptive Medicine ETF

FMED is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers.

Fidelity Disruptive Automation ETF

Fidelity Disruptive Communications ETF

Fidelity Disruptive Finance ETF

Fidelity Disruptors ETF

Fidelity Disruptive Technology ETF

Thematic investing continues to garner attention at the midyear point on sustained artificial intelligence interest. For advisors and investors looking to diversify their thematic holdings, the Disruptive ETF suite from Fidelity offers strategies cutting across several sectors.

An Advisor's Guide to Fidelity's Disruptive ETF Suite

Could healthcare innovation be one potent opportunity area to start 2024? Healthcare investing wasn't necessarily the best in 2023.

Eye Disruptive Medicine ETF FMED to Start 2024

Fidelity Blue Chip Growth ETF

Fidelity Total Bond ETF

Fidelity Covington Trust-Fidelity Crypto Industry And Digital Payments Etf

Fidelity MSCI Real Estate ETF

Fidelity MSCI Information Technology Index ETF

In the latest big news for the burgeoning ETF landscape, Fidelity will convert six mutual funds to ETFs. The firm's suite will see its thematic ETFs investing roster expand and diversify significantly.

Fidelity Converts Six Funds to Thematic ETFs

The timeline for the conversion of six thematic equity mutual funds from Fidelity focused on different facets of the disruptive innovation theme into ETFs is taking shape. The latest filing by the issuer outlines the details of the funds and their conversion dates.

Fidelity Thematic Funds to Convert Within 2 Weeks

News for Fidelity Disruptive Medicine ETF ETF (FMED)